Procter & Gamble CDR [Cad Hedged] (PG.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 12-2019 | 06-2019 | 12-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 3,013,000 | 20,726 | 2,824,000 | 25,905 | 2,834,000 |
| Income taxes - deferred | -596,000 | -485 | -411,000 | -1,952 | -1,844,000 |
| Accounts receivable | 634,000 | 9,048 | -276,000 | -11,993 | -177,000 |
| Accounts payable and accrued liabilities | 1,923,000 | 34,094 | 1,856,000 | -399 | 1,385,000 |
| Other Working Capital | 1,210,000 | 35,613 | 368,000 | -7,899 | 3,020,000 |
| Other Operating Activity | 11,219,000 | -75,767 | 10,881,000 | -14,354 | 9,649,000 |
| Operating Cash Flow | $17,403,000 | $23,229 | $15,242,000 | $-10,692 | $14,867,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 6,215 | N/A | 14 | N/A |
| Net Acquisitions | -58,000 | N/A | -3,945,000 | N/A | -109,000 |
| Purchase Of Investment | -5,000 | N/A | -220,000 | 0 | -3,909,000 |
| Sale Of Investment | 6,151,000 | 66 | 3,628,000 | 178 | 3,955,000 |
| Other Investing Activity | -3,043,000 | -53,273 | -2,953,000 | -28,168 | -3,448,000 |
| Investing Cash Flow | $3,045,000 | $-46,992 | $-3,490,000 | $-27,976 | $-3,511,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,345,000 | N/A | -2,215,000 | N/A | -3,437,000 |
| Debt Issued | 4,951,000 | 17,500 | 2,367,000 | N/A | 5,072,000 |
| Debt Repayment | -2,447,000 | -218 | -969,000 | -20,050 | -2,873,000 |
| Common Stock Issued | N/A | 11,517 | N/A | N/A | N/A |
| Common Stock Repurchased | -7,405,000 | N/A | -5,003,000 | N/A | -7,004,000 |
| Dividend Paid | -7,789,000 | 0 | -7,498,000 | 0 | -7,310,000 |
| Other Financing Activity | 1,978,000 | 7,377 | 3,324,000 | -699 | 1,177,000 |
| Financing Cash Flow | $-8,367,000 | $36,176 | $-9,994,000 | $-20,749 | $-14,375,000 |
| Exchange Rate Effect | -139,000 | 2,113 | -88,000 | 253 | 19,000 |
| Beginning Cash Position | 4,239,000 | 43,882 | 2,569,000 | 103,046 | 5,569,000 |
| End Cash Position | 16,181,000 | 58,408 | 4,239,000 | 43,882 | 2,569,000 |
| Net Cash Flow | $12,081,000 | $12,413 | $1,758,000 | $-59,417 | $-3,019,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,403,000 | 23,229 | 15,242,000 | -10,692 | 14,867,000 |
| Capital Expenditure | -3,073,000 | -52,025 | -3,347,000 | -26,873 | -3,717,000 |
| Free Cash Flow | 14,330,000 | -28,796 | 11,895,000 | -37,565 | 11,150,000 |